The effects of hormone replacement therapy on coronary heart disease

Endocrinology and Metabolism Clinics of North America

Volumn 26, Issue 2, 1997, Pages 313-328

  Sotelo, M M ^a   Johnson, S R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; LIPOPROTEIN;

ARTICLE; CARBOHYDRATE METABOLISM; DISEASE ASSOCIATION; DRUG EFFICACY; ESTROGEN DEFICIENCY; FEMALE; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MENOPAUSE; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0030979320     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70249-8     Document Type: Article

References (70)

1. American College of Physicians Guidelines for counseling postmenopausal women about preventive hormone therapy Ann Intern Med 117 1992 1038 1041
2. E. Barrett-Connor Postmenopausal estrogen and prevention bias Ann Intern Med 115 1991 455 456
3. E. Barrett-Connor T.L. Bush Estrogen and coronary heart disease in women [review] JAMA 265 1991 1861 1867
4. E. Barrett-Connor M. Laakso Ischemic heart disease risk in postmenopausal women: Effects of estrogen use on glucose and insulin levels Arteriosclerosis 10 1990 531 534
5. K.M. Bass C.J. Newschaffer M.J. Klag Plasma lipoprotein levels as predictors of cardiovascular death in women Arch Intern Med 153 1993 2209 2216
6. J. Blumberg G. Block The alpha-tocopherol, beta-carotene cancer prevention study in Finland Nutr Rev 52 1994 242 245
7. A.G. Boston D.R. Gagnon L.A. Cupples A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women: The Framingham Heart Study Circulation 90 1994 1688 1695
8. K.M. Brett J.H. Madans Long-term survival after coronary heart disease: Comparisons between men and women in a national sample [see comments] Ann Epidemiol 5 1995 25 32
9. J.A. Cauley S.R. Cummings D.M. Black Prevalence and determinants of estrogen replacement therapy in elderly women Am J Obstet Gynecol 163 5 pt 1 1990 1438 1444
10. T.B. Clarkson C.L. Hughes K.P. Klein The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease [review] Prog Cardiovasc Dis 38 1995 189 198
11. M.H. Criqui L. Suarex E. Barrett-Connor Postmenopausal estrogen use and mortality: Results from a prospective study in a defined, homogeneous community Am J Epidemiol 128 1988 606 614
12. J. Dallongeville N. Marecaux D. Isorez Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women Atherosclerosis 118 1995 123 133
13. E. Daly M.P. Vessey D. Barlow Hormone replacement therapy in a risk-benefit perspective Maturitas 23 1996 247 259
14. C.A. Derby A.L. Hume J.B. McPhillips Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers Am J Obstet Gynecol 173 1995 544 550
15. B. Ettinger G.D. Friedman T. Bush Reduced mortality associated with long-term postmenopausal estrogen therapy Obstet Gynecol 87 1996 6 12
16. L. Fahraeus The effects of estradiol on blood lipids and lipoproteins in postmenopausal women [review] Obstet Gynecol 72 5 suppl 1988 18S 22S
17. M. Falkeborn I. Persson H.O. Adami The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement Br J Obstet Gynaecol 99 1992 821 828
18. A. Ferrara E.L. Barrett-Connor S.L. Edelstein Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: The Rancho Bernardo Study, 1984–1991 Am J Epidemiol 140 1994 857 869
19. A.R. Folsom P.J. Mink T.A. Sellers Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women Am J Public Health 85 1995 1128 1132
20. M. Gerhard P. Ganz How do we explain the clinical benefits of estrogen? From bedside to bench [review] Circulation 92 1995 5 8
21. D. Grady S.M. Rubin D.B. Petitti Hormone therapy to prevent disease and prolong life in postmenopausal women [see comments] [review] Ann Intern Med 117 1992 1016 1037
22. F. Grodstein M. Stampfer The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women [review] Prog Cardiovasc Dis 38 1995 199 210
23. F. Grodstein M.J. Stampfer J.E. Manson Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
24. R.B. Harris A. Laws V.M. Reddy Are women using postmenopausal estrogens? A community survey Am J Public Health 80 1990 1266 1268
25. E. Hemminki S. Sihvo A review of postmenopausal hormone therapy recommendations: Potential for selection bias Obstet Gynecol 82 1993 1021 1028
26. B.E. Henderson A. Paganini-Hill R.K. Ross Decreased mortality in users of estrogen replacement therapy Arch Intern Med 151 1991 75 78
27. C.H. Hennekens J.E. Buring J.E. Manson Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease [see comments] N Engl J Med 334 1996 1145 1149
28. R.J. Jarrett The cardiovascular risk associated with impaired glucose tolerance [review] Diabetic Med 13 3 suppl 2 1995 S15 S19
29. S.R. Johnson Should older women use estrogen replacement [editorial; comment]? J Am Geriatr Soc 44 1996 89 90
30. W.B. Kannel M.C. Hjortland P.M. McNamara Menopause and risk of cardiovascular disease: The Framingham study Ann Intern Med 85 1976 447 452
31. W.B. Kannel P.A. Wolf W.P. Castelli Fibrinogen and risk of cardiovascular disease: The Framingham Study JAMA 258 1987 1183 1186
32. R.H. Knopp X. Zhu B. Bonet Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women [review] Atherosclerosis 110 suppl 1994 S83 S91
33. R.L. Levine S.J. Chen J. Durand Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery Circulation 94 1996 2221 2227
34. E.H. Lieberman M.D. Gerhard A. Uehata Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women Ann Intern Med 121 1994 936 941
35. T.A. Manolio C.D. Furberg L. Shemanski Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women: The CHS Collaborative Research Group Circulation 88 5 pt 1 1993 2163 2171
36. K.A. Matthews L.H. Kuller R.R. Wing Prior to use of estrogen replacement therapy, are users healthier than nonusers [see comments]? Am J Epidemiol 143 1996 971 978
37. K.A. Matthews R.R. Wing L.H. Kuller Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women Arch Intern Med 154 1994 2349 2355
38. T.W. Meade S. Mellows M. Brozovic Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study [see comments] Lancet 2 8506 1986 533 537
39. Medical Research Council's General Practice Research Framework Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy BMJ 312 7029 1996 473 478
40. V.T. Miller R.A. Muesing J.C. LaRosa Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolpoprotein A-1 Obstet Gynecol 77 1991 235 240
41. A.A. Nabulsi A.R. Folsom A. White Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: Atherosclerosis Risk in Community Study N Engl J Med 328 1993 1069 1075
42. L.E. Nachtigall R.H. Nachtigall R.D. Nachtigall Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems Obstet Gynecol 54 1979 74 79
43. Office of Technology Assessment, US Congress Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy, vol I. Cost-Effectiveness Analysis August 1995 US Government Printing Office Washington, DC Publication No. OTA-BP-H-160
44. G.S. Omenn G.E. Goodman M.D. Thornquist Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease [see comments] N Engl J Med 334 1996 1150 1155
45. D.B. Petitti Coronary heart disease and estrogen replacement therapy: Can compliance bias explain the results of observational studies? Ann Epidemiol 4 1994 115 118
46. A. Pines E.Z. Fisman D. Ayalon Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women Chest 102 1992 1496 1498
47. R.L. Prentice J.E. Rossouw S.R. Johnson The role of randomized controlled trials in assessing the benefits and risks of long-term hormone replacement therapy: Example of the Women's Health Initiative Menopause 3 1996 71 76
48. B.M. Psaty S.R. Heckbert D. Atkins The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women Arch Intern Med 154 1994 1333 1339
49. S.E. Reis S.T. Gloth R.S. Blumenthal Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women Circulation 89 1994 52 60
50. G.M.C. Rosano P.M. Sarrel S.L. Chierchia Medroxyprogesterone but not natural progesterone reverses the beneficial effect of estradiol 17-beta upon exercise-induced myocardial ischemia [abstract] Circulation 94 suppl 1996 I-18
51. G.M. Rosano P.M. Sarrel P.A. Poole-Wilson Beneficial effect of oestroen on exercise-induced myocardial ischaemia in women with coronary artery disease Lancet 342 8864 1993 133 136
52. V. Salomaa V. Rasi J. Pekkanen Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors: The Finrisk Hemostasis Study Arteriosclerosis Thromb Vasc Biol 15 1995 1549 1555
53. S.A. Samaan M.H. Crawford Estrogen and cardiovascular function after menopause [review] J Am Coll Cardiol 26 1995 1403 1410
54. P.M. Sarrel How progestins compromise the cardioprotective effects of estrogens [editorial review] Menopause 2 1995 187 190
55. E. Shahar A.R. Folsom V.V. Salomaa Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators Circulation 93 1996 1970 1975
56. D.C. Smith R. Prentice J.T. Donovan Association of exogenous estrogen and endometrial carcinoma N Engl J Med 293 1975 1164 1167
57. L. Speroff J. Rowan J. Symons The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study): A randomized controlled trial JAMA 276 1996 1397 1403
58. M.J. Stampfer G.A. Colditz Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence [review] Prev Med 20 1991 47 63
59. J.C. Stevenson A.J. Proudler C. Walton HRT mechanisms of action: Carbohydrates [review] Int J Fertil Menopausal Studies 39 suppl 1 1994 50 55
60. S.R. Sturgeon C. Schairer L.A. Brinton Evidence of a healthy estrogen user survivor effect Epidemiology 6 1995 227 231
61. J.M. Sullivan Coronary arteriography in estrogen-treated postmenopausal women [review] Prog Cardiovasc Dis 38 1995 211 222
62. J.M. Sullivan B.A. Shala L.A. Miller Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy Menopause 2 1995 193 199
63. J.M. Sullivan R. Vander Zwaag J.P. Hughes Estrogen replacement and coronary artery disease: Effect on survival in postmenopausal women Arch Intern Med 150 1990 2557 2562
64. S.G. Thompson T.W. Meade G. Greenberg The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women J Epidemiol Community Health 43 1989 173 178
65. M.J. Tikkanen Mechanisms of cardiovascular protection by postmenopausal hormone replacement therapy [review] Cardiovasc Risk Factors 3 1993 138 143
66. S.M. Vaziri J.C. Evans M.G. Larson The impact of female hormone usage on the lipid profile: The Framingham offspring study Arch Intern Med 153 1993 2200 2206
67. C.P. Weiner I. Lizasoain S.A. Baylis Induction of calcium-dependent nitric oxide synthases by sex hormones Proc Natl Acad Sci USA 91 1994 5212 5216
68. R.A. Wild Estrogen: Effects on the cardiovascular tree [review] Obstet Gynecol 87 1996 27S 35S
69. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial [see comments] JAMA 273 1995 199 208
70. The Writing Group for the PEPI Trial Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 275 1996 370 375